Anti-malarial Drugs Market Insights 2020 | Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG

Malaria has affected the tropical regions in the world including Africa and Asia, Central and South America, Haiti and the Dominican Republic, some parts of Middle East, and some Pacific islands. The increasing cases of traveler’s malaria is one of the factors contributing to growth of the market. Every year, thousands of people worldwide travel to such malaria affected regions, which is expected to increase the risk of infection. For instance, according to Global Health, Division of Parasitic Diseases and Malaria, and (CDC), each year, around 2,000 cases of malaria are diagnosed in the U.S. To avoid the increasing number of patient pool and to reduce the risk of traveler’s malaria, travelers are being advised by the regulatory authorities to have the antimalarial medicines with them.

Medicines for Malaria Venture (MMV) is a not-for-profit public-private partnership, which was established in 1999, with an aim to reduce the burden of malaria in disease-endemic countries by developing novel treatment options. Many of the key pharmaceutical companies have been collaborating with MMV in order to develop novel drug entity for the treatment of malaria. For instance, in December 2019, Ipca Laboratories entered into a collaboration agreement with Medicines for Malaria Venture to develop a novel antimalarial co-formulation, Atoguanil, a combination of atovaquone and proguanil.

Get Free Request a sample Copy of Anti-malarial Drugs Market at: https://www.coherentmarketinsights.com/insight/request-sample/3726

Moreover, rising funding by regional governments is significantly contributing to growth of the global anti-malaria drugs market. These funding are expected to give opportunity for research institutes such as Medicines for Malaria Venture, in order to continue the research studies for potential lead candidates targeting malaria. For instance, in November 2017, United States Agency for International Development (USAID) granted funding of US$ 9 million to Medicines for Malaria Venture for 5 years to conduct the three project including pharmacovigilance study of Pyramax (pyronaridine-artesunate), SERC Phase III study to develop a single-exposure radical cure, and to study the efficacy of DSM265, a potential single-exposure radical cure.

The new research report on Anti-malarial Drugs market offers a thorough analysis of this industry vertical. As per the report, Anti-malarial Drugs market is predicted to acquire notable gains and record a significant growth during the estimated timeframe.

The Anti-malarial Drugs market report emphasizes on the current industry trends and entails details about market size, revenue forecast, and sales volume over the study duration. In addition, the report provides data with regards to the market drivers that will positively influence the revenue graph, alongside the segmentations influencing the industry size.

Some of the key players/Manufacturers involved in the Anti-malarial Drugs Market
Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc.

Key Benefits:

• This study gives a detailed analysis of drivers and factors limiting the market expansion of Anti-malarial Drugs

• The micro-level analysis is conducted based on its product types, end-user applications, and geographies

• Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

• By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Anti-malarial Drugs market

Apply Promo Code "CHRISTMAS2020" And Get Instant Discount Of USD 1000

Ask for Discount on Anti-malarial Drugs Market Report at: https://www.coherentmarketinsights.com/insight/request-discount/3726

**Note: Year End Discount

If you purchase the report this year:

Flat 20% instant discount

25% discount on 2nd report

15 % free customization

Reasons to Buy a Full Report
• In depth analysis by industry experts
• Use of data triangulation method for examining the various aspects of the market
• Detailed profiling of the major competitors in the market
• A complete overview of the market landscape
• Computed Annual Growth Rate is calculated for period, 2020-2027

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Anti-malarial Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Anti-malarial Drugs , with price, sales, revenue and global market share of Anti-malarial Drugs in 2018 and 2020.

Chapter 3, the Anti-malarial Drugs market trends competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anti-malarial Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2020.

Chapter 12, Anti-malarial Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Anti-malarial Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.